• Day All
• March 28 (Thursday)
• March 29 (Friday)
• March 30 (Saturday)

March 29 (Friday)

[JS03] Joint Session 03: ASH-KSH Joint Symposium - Ped-ALL Room 1

• March 29 (Friday), 09:00-10:15
• Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea), Wendy Stock (University of Chicago, USA)
• 09:00-09:16 Pediatric and AYA ALL: Lessons learned from children’s oncology group clinical trials Sarah K. Tasian (The Children’s Hospital of Philadelphia, USA) 09:16-09:32 Multicenter trials investigating childhood acute lymphoblastic leukemia in South Korea Hyery Kim (University of Ulsan College of Medicine, Korea) 09:32-09:48 Dissecting the Developmental Origins of Acute Leukemia Charles G. Mullighan (St. Jude Children’s Research Hospital, USA) 09:48-10:04 Unveiling precision medicine: RNA and DNA sequencing in targeted therapy for Korean pediatric leukemia Myung-Shin Kim (The Catholic University of Korea College of Medicine, Korea)

[ES03] Education Session 03: Leaps and hurdles in transfusion medicine (Kor) Room 2

• March 29 (Friday), 09:00-10:15
• Duck Cho (Sungkyunkwan University School of Medicine, Korea), Jihyang Lim (The Catholic University of Korea College of Medicine, Korea)
• 09:00-09:25 Comprehensive overview of cell-based artificial platelet production Seung Yeob Lee (Jeonbuk National University Medical School, Korea) 09:25-09:50 Anti-CD38 and anti-CD47 delay timely transfusion Hyungsuk Kim (Seoul National University College of Medicine, Korea) 09:50-10:15 Reappraisal of transfusion-transmitted infections Dae-Hyun Ko (University of Ulsan College of Medicine, Korea)

[SS09] Scientific Session 09: Clonal hematopoiesis: What should we know? Room 3

• March 29 (Friday), 09:00-10:15
• Myung Geun Shin (Chonnam National University Medical School, Korea), Hyun Kyung Kim (Seoul National University College of Medicine, Korea)
• 09:00-09:25 Clonal hematopoiesis and aging Siddhartha Jaiswal (Stanford University School of Medicine, USA) 09:25-09:50 Clonal hematopoiesis: Implications for cell therapy Adam S. Sperling (Dana-Farber Cancer Institute, USA) 09:50-10:15 Clonal Hematopoiesis and Metabolic Disorders Sung Hee Choi (Seoul National University College of Medicine, Korea)

[SS10] Scientific Session 10: Predictive biomarkers in multiple myeloma Room 4

• March 29 (Friday), 09:00-10:15
• Chang-Ki Min (The Catholic University of Korea College of Medicine, Korea), Jeong Yeal Ahn (Gachon University College of Medicine, Korea)
• 09:00-09:25 The impact of immune profiling of T-cell and plasma cells on non-cellular immune therapy in myeloma Nizar J Bahlis (University of Calgary, Canada) 09:25-09:50 Single-cell techniques to characterize immune microenvironment in MM Niels Weinhold (Univ Hosp Heidelberg, Germany) 09:50-10:15 The power of ONE: Immunology in the age of single cell genomics Ido Amit (Weizmann Institute of Science, Israel)

[PL02] Plenary Lecture 02 Room 1+2

• March 29 (Friday), 10:30-11:15
• Chuhl Joo Lyu (Yonsei University College of Medicine, Korea)
• 10:30–11:15 How to win: Competitive strategies in the hematopoietic stem cell niche Margaret Goodell (Baylor College of Medicine, USA)

[SY05] Satellite Symposium 05: BMS Room 1

• March 29 (Friday), 12:15-13:05
• Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
• 12:15-13:05 Continued hope with ONUREG - A new maintenance therapy to treat AML Esther Oliva (Grande Ospedale Metropolitano Bianchi Melacrino Morelli)

[SY06] Satellite Symposium 06: Kyowa Kirin Room 2

• March 29 (Friday), 12:15-13:05
• Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)
• 12:15-13:05 Mogamulizumab: A new era in MF/SS management - Clinical evidence and practical consideration Francine Foss (Yale University School of Medicine)

[SY07] Satellite Symposium 07: Novartis Room 3

• March 29 (Friday), 12:15-13:05
• Dong-Wook Kim (Eulji University School of Medicine, Korea)
• 12:15-13:05 TKI treatment pattern and new therapy of CML Qian Jiang (Peking University People's Hospital)

[SY08] Satellite Symposium 08: Handok Room 4

• March 29 (Friday), 12:15-13:05
• Hyeon-Seok Eom (National Cancer Center, Korea)
• 12:15-13:05 The optimal treatment strategy for transplant-ineligible relapsed/refractory DLBCL Kwai Han Yoo (Gachon University College of Medicine)

[JS04] Joint Session 04: Current interests in hematologic disease in Asia Room 1

• March 29 (Friday), 15:05-16:20
• Soo-Mee Bang (Seoul National University College of Medicine, Korea), Byeong-Bae Park (Hanyang University College of Medicine, Korea)
• 15:05-15:25 The journey of bone marrow transplantation at BachMai General Hospital Han Viet Trung (Journey of transplantation in Bach Mai General Hospital, Vietnam) 15:25-15:45 Current situation of management of non-hodgkin lymphoma in the Republic of Armenia Yervand Hakobyan (Armenian Hematology Association, Armenia) 15:55-16:20 The evolution of hemophilia treatment in Thailand Darintr Sosothikul (Chulalongkorn University, Thailand)

[SS11] Scientific Session 11: Quality-of-life revisited Room 2

• March 29 (Friday), 15:05-16:20
• Sung Yong Oh (Dong-A University College of Medicine, Korea), Yong Park (Korea University College of Medicine, Korea)
• 15:05-15:30 End-of-life care in children with hematologic malignancies Min Sun Kim (Seoul National University College of Medicine, Korea) 15:30-15:55 Long-term survivorship in hematologic malignancies Shahrukh K. Hashmi (Mayo Clinic, USA) 15:55-16:20 The importance of monitoring symptoms and quality of life in routine hematology practice Fabio Efficace (Italian Group for Adult Hematologic Diseases, Italy)

[SS12] Scientific Session 12: Novel approaches for diagnosis & treatment of acute lymphoblastic leukemia Room 3

• March 29 (Friday), 15:05-16:20
• Hyoung Jin Kang (Seoul National University College of Medicine, Korea), Ho-Jin Shin (Pusan National University School of Medicine, Korea)
• 15:05-15:30 Novel approaches for diagnosis & treatment of acute lymphoblastic and myeloid leukemia Michel Zwaan (Princess Ma´xima Center for Pediatric Oncology, The Netherlands) 15:30-15:55 The role of blinatumomab in the treatment of MRD negative B-ALL in adults Mark R. Litzow (Mayo Clinic, USA) 15:55-16:20 Revised WHO classification of ALL: New era of genetic diagnosis Ari Ahn (The Catholic University of Korea College of Medicine, Korea)

[ES04] Education Session 04: Monoclonal gammopathies of clinical significance Room 4

• March 29 (Friday), 15:05-16:20
• Young Rok Do (Keimyung University School of Medicine, Korea), Hyo Jung Kim (Hallym University College of Medicine, Korea)
• 15:05-15:30 AL cardiac amyloidosis Darae Kim (Sungkyunkwan University School of Medicine, Korea) 15:30-15:55 Nephrologist’s perspective on monoclonal gammopathy of renal significance Soon Hyo Kwon (Soonchunhyang University College of Medicine, Korea) 15:55-16:20 Monoclonal gammopathies of neurological significance Ju-Hong Min (Sungkyunkwan University School of Medicine, Korea)

[SS13] Scientific Session 13: Advancing in knowledge of rare pediatric hematologic disorders Room 2

• March 29 (Friday), 16:35-17:50
• Ho Joon Im (University of Ulsan College of Medicine, Korea), Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea)
• 16:35-17:00 Clonal evolution of MDS/AML in patients with cancer predisposition syndromes Kenichi Yoshida (National Cancer Center Research Institute, Japan) 17:00-17:25 Congenital & aquired thrombophilic conditions in children Leonardo R. Brandão (University of Toronto, Canada) 17:25-17:50 Management of rare pediatric lymphomas Jae Wook Lee (The Catholic University of Korea College of Medicine, Korea)

[JS05] Joint Session 05: Asian Hematology Session II - AML Room 3

• March 29 (Friday), 16:35-17:50
• Sangkyun Sohn (Kyungpook National University School of Medicine, Korea), Byong Soo Kim (Korea University College of Medicine, Korea)
• 16:35-16:55 Epidemiology, risk stratification and treatment outcome in acute myeloid treatment: Taiwan experience Hsin-An Hou (National Taiwan University, Taiwan) 16:55-17:15 Advancement in leukaemia diagnostics: the role of next-generation sequencing (NGS) in acute myeloid leukaemia in Malaysia Angeli Ambayya (Ministry of Health, Malaysia) 17:15-17:35 Determining fitness for treatments in older adults with AML Byung Sik Cho (The Catholic University of Korea College of Medicine, Korea)

[ES05] Education Session 05: Principles of anticoagulation - All about blood clots (Kor) Room 4

• March 29 (Friday), 16:35-17:50
• Soo-Mee Bang (Seoul National University College of Medicine, Korea), Sung Hwa Bae (Daegu Catholic University School of Medicine, Korea)
• 16:35-17:00 Back to the basic: coagulation pathway Seonyang Park (Inje University Haeundae Paik Hospital, Korea) 17:00-17:25 Pharmacology: Anticoagulants and reversal agents Seo-Yeon Ahn (Chonnam National University College of Medicine, Korea) 17:25-17:50 Proper application of anticoagulation therapy on CAT Ho-Young Yhim (Jeonbuk National University Medical School, Korea)